Data-driven personalization of a physiologically based pharmacokinetic model for caffeine: A systematic assessment

Abstract:

Physiologically based pharmacokinetic (PBPK) models have been proposed as a tool for more accurate individual pharmacokinetic (PK) predictions and model-informed precision dosing, but their application in clinical practice is still rare. This study systematically assesses the benefit of using individual patient information to improve PK predictions. A PBPK model of caffeine was stepwise personalized by using individual data on (1) demography, (2) physiology, and (3) cytochrome P450 (CYP) 1A2 phenotype of 48 healthy volunteers participating in a single-dose clinical study. Model performance was benchmarked against a caffeine base model simulated with parameters of an average individual. In the first step, virtual twins were generated based on the study subjects' demography (height, weight, age, sex), which implicated the rescaling of average organ volumes and blood flows. The accuracy of PK simulations improved compared with the base model. The percentage of predictions within 0.8-fold to 1.25-fold of the observed values increased from 45.8% (base model) to 57.8% (Step 1). However, setting physiological parameters (liver blood flow determined by magnetic resonance imaging, glomerular filtration rate, hematocrit) to measured values in the second step did not further improve the simulation result (59.1% in the 1.25-fold range). In the third step, virtual twins matching individual demography, physiology, and CYP1A2 activity considerably improved the simulation results. The percentage of data within the 1.25-fold range was 66.15%. This case study shows that individual PK profiles can be predicted more accurately by considering individual attributes and that personalized PBPK models could be a valuable tool for model-informed precision dosing approaches in the future.

SEEK ID: https://seek.lisym.org/publications/331

PubMed ID: 34053199

DOI: 10.1002/psp4.12646

Projects: LiSyM Pillar II: Chronic Liver Disease Progression (LiSyM-DP)

Publication type: Journal

Journal: CPT Pharmacometrics Syst Pharmacol

Publisher: Wiley

Citation: Fendt R, Hofmann U, Schneider ARP, Schaeffeler E, Burghaus R, Yilmaz A, Blank LM, Kerb R, Lippert J, Schlender JF, Schwab M, Kuepfer L. Data-driven personalization of a physiologically based pharmacokinetic model for caffeine: A systematic assessment. CPT Pharmacometrics Syst Pharmacol. 2021 May 30. doi: 10.1002/psp4.12646. Epub ahead of print. PMID: 34053199.

Date Published: 30th May 2021

URL: https://ascpt.onlinelibrary.wiley.com/doi/10.1002/psp4.12646

Registered Mode: manually

Authors: Rebekka Fendt, Ute Hofmann, Annika Schneider, Elke Schaeffeler, Rolf Burghaus, Ali Yilmaz, Lars Mathias Blank, Reinhold Kerb, Jan-Frederik Schlender, Matthias Schwab, Lars Kuepfer

Help
help Submitter
Citation
Fendt, R., Hofmann, U., Schneider, A. R. P., Schaeffeler, E., Burghaus, R., Yilmaz, A., Blank, L. M., Kerb, R., Lippert, J., Schlender, J. F., Schwab, M., & Kuepfer, L. (2021). Data‐driven personalization of a physiologically based pharmacokinetic model for caffeine: A systematic assessment. CPT: Pharmacometrics & Systems Pharmacology. https://doi.org/10.1002/psp4.12646
Activity

Views: 151

Created: 30th Jun 2021 at 14:26

Last updated: 30th Jun 2021 at 14:29

help Tags

This item has not yet been tagged.

help Attributions

None

Related items

Powered by
(v.1.11.1)
Copyright © 2008 - 2021 The University of Manchester and HITS gGmbH